Tandem Diabetes Care, Inc.
Clinical trials sponsored by Tandem Diabetes Care, Inc., explained in plain language.
Medical device company making insulin pumps for diabetes.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New insulin set aims to last a full week for type 1 diabetes
Disease control OngoingThis study tests a new insulin infusion set designed to last up to 7 days for people with type 1 diabetes. Twenty adults currently using a Tandem insulin pump and Dexcom CGM will try the SteadiSet at home. The goal is to see if the set can survive a full week without causing high…
Phase: NA • Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New insulin pump software tested in kids as young as 2
Disease control OngoingThis study is checking how safe and effective an updated insulin pump system (Control-IQ 1.5) is for children ages 2 to 6 with type 1 diabetes. About 144 kids will use the pump for a year while researchers track dangerous low blood sugar events and diabetic ketoacidosis. The goal…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC